Suchergebnisse - "Ohmachi, K"

PubPharm (22)

1

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma : a multicenter phase II study

enthalten in: Annals of hematology | 2019

von Sakai, R. | Ohmachi, K. | Sano, F. | +16

2

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study

enthalten in: Annals of hematology | 2019

von Sakai, R. | Ohmachi, K. | Sano, F. | +16

3

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study

enthalten in: Annals of hematology | 2019

von Sakai, R. | Ohmachi, K. | Sano, F. | +16

4

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study

enthalten in: Annals of hematology | 2019

von Sakai, R. | Ohmachi, K. | Sano, F. | +16

5

A PHASE II STUDY OF THP (PIRARUBICIN)‐COP THERAPY IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED PTCL : THP‐3 STUDY OF JAPAN HEMATOPOIETIC MALIGNANCY CLINICAL STUDY GROUP

enthalten in: Hematological Oncology | 2019

von Ogura, M. | Ohmachi, K. | Suzuki, R. | +16

6

ONO‐4059 (GS‐4059), A NEXT GENERATION BTK INHIBITOR, MONOTHERAPY IN PATIENTS WITH B‐CELL MALIGNANCIES IN THE JAPANESE PHASE 1, DOSE‐ESCALATION STUDY

enthalten in: Hematological oncology | 2017

von Ando, K. | Hatake, K. | Fukuhara, N. | +8

7

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

enthalten in: Blood cancer journal | 2015

von Aoki, T. | Shimada, K. | Suzuki, R. | +16

8

Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Chihara, D. | Asano, N. | Ohmachi, K. | +11

9

Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

enthalten in: Annals of oncology | 2015

von Chihara, D. | Asano, N. | Ohmachi, K. | +11

10

Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients

enthalten in: Blood cancer journal | 2013

von Watanabe, T. | Mitsuhashi, M. | Sagawa, M. | +9